Development of molecular Trojan horses targeting New Delhi metallo-β-lactamase-1 for the restoration of meropenem susceptibility in drug-resistant bacteria.

Documenti analoghi

• Structure-Directed Optimization of Ebselen Derivatives as Potent NDM-1 Inhibitors Reverses Meropenem Resistance.
  di: Guo, Yan, et al.
  Pubblicazione: (2025)
• The New Delhi Metallo-β-lactamase-1 Covalent Inhibitors Derived from Cephalexin Effectively Reverse Meropenem Resistance.
  di: Liu, Wandong, et al.
  Pubblicazione: (2026)
• The impact of aztreonam-clavulanic acid exposure on gene expression and mutant selection using a multidrug-resistant .
  di: Lin, Tongtong, et al.
  Pubblicazione: (2025)
• Optimized ebselen derivatives as novel potent Escherichia coli β-glucuronidase covalent allosteric inhibitors.
  di: Ying, Ti-Ti, et al.
  Pubblicazione: (2025)
• Computer-aided screening of marine fungal metabolites as potential inhibitors of new Delhi metallo-beta-lactamase-1.
  di: Shabbir, Farhat, et al.
  Pubblicazione: (2025)